BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $452 | +43.0% | 9 | +80.0% | 0.00% | – |
Q2 2023 | $316 | +40.4% | 5 | 0.0% | 0.00% | – |
Q1 2023 | $225 | +2.7% | 5 | 0.0% | 0.00% | – |
Q4 2022 | $219 | – | 5 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 5 | -44.4% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 9 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 9 | -40.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | -66.7% | 15 | -37.5% | 0.00% | -100.0% |
Q4 2020 | $3,000 | +50.0% | 24 | -4.0% | 0.00% | – |
Q3 2020 | $2,000 | +100.0% | 25 | +38.9% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 18 | -25.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 24 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 24 | -4.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 25 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 25 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 25 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |